Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors
Phase: N/A
Priority: Normal
Start: 06/24/21
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 01/07/21
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 09/14/17
End: 10/23/19
Due: 10/23/20
Phase: N/A
Priority: Normal
Start: 12/19/21
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 09/14/17
End: 06/24/19
Due: 06/24/20